
We are a biopharmaceutical company developing targeted immunotherapeutics for cancer.
Our team includes founders of 3 Biotech companies, with decades of experience and approved products.
Our mission is to provide cures for serious diseases, but without sacrificing the patient’s quality of life.
Today, our cancer drug candidate is in pre-clinical development.
